The DOI matches its Crossref record.
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
Abstract
In vivo microdialysis was used to assess the involvement of ventral tegmental area (VTA) mu, delta, and kappa opioid receptors in modulation of basal extracellular ventral striatal dopamine (DA) and DA-metabolite concentrations. Independent groups of chloral hydrate-anesthetized rats were given VTA microinjections of selective opioid agonists, and extracellular ventral striatal DA and DA-metabolite concentrations were assayed using HPLC. VTA microinjections of [D-Ala2, N-Me-Phe4-Gly5-ol]-enkephalin (DAMGO; a mu agonist) and [D-Pen2, D-Pen5]-enkephalin (DDDPE; a delta agonist) each caused dose-orderly increases in ventral striatal DA and DA-metabolite concentrations. The effective concentrations of DPDPE were 100- to 1000-fold higher than the effective concentrations of DAMGO. VTA microinjections of (trans-(dl)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclo-hexyl]- benzeneacetamide) methane sulfonate hydrate (U-50,488H); a kappa agonist) failed to alter ventral striatal DA concentrations at any dose tested, but subsequent systemic injections significantly decreased DA and DA-metabolite concentrations. Pretreatment with VTA microinjections of 17-cyclopropylmethyl-6,7-dehydro-4,5-epoxy-3,14-dihydroxy-6,7,2',3'- indolmorphinan hydrochloride (naltrindole; a delta antagonist) (delta antagonist) antagonized VTA DPDPE-mediated increases in ventral striatal DA and DA-metabolite concentrations but failed to antagonize VTA DAMGO-mediated increases. Pretreatment with D-Pen-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP; a mu antagonist) antagonized VTA DAMGO-mediated increases but failed to antagonize VTA DPDPE-mediated increases. Thus both mu and delta receptor agonist appear capable of increasing ventral striatal DA and DA-metabolite concentrations through selective actions on their preferred class of opioid receptors in the VTA. The increases in ventral striatal DA and DA-metabolite concentrations that are seen after systemic treatment with kappa opioid agonists appear not to involve VTA opioid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, dynorphins decrease and enkephalins increase the release of DA (Devine et al. 1993; Di Chiara & Imperato 1988; Longoni et al. 1991; Pentney & Gratton 1991; Spanagel et al. 1990a,b, 1992).”
From Reward, addiction, withdrawal to nicotine (2011) · cites this paper as Devine et al. 1993
In the citing paper
“may reflect known interactions between the dopamine and endorphin systems in both humans and rodents (40, 55, 56), whereby endorphin activation may itself trigger a dopamine response”
From Variation in the β-endorphin, oxytocin, and dopamine receptor genes is associated with different dimensions of human sociality (2017) · cites this paper as [56]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 384
Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids
Cai, N.-S., Quiroz, C., Bonaventura, J., Bonifazi, A., Cole, T. O., Purks, J., Billing, A. S., Massey, E. C., Wagner, M., Wish, E. D., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126912 · Cited by 71
Hutcheson, D. M., Parkinson, J. A., Robbins, T. W., & Everitt, B. J. (2000) · Psychopharmacology · doi:10.1007/s002130000635 · Cited by 70
Roles of Nucleus Accumbens CREB and Dynorphin in Dysregulation of MotivationPreprint
Muschamp, J. W., & Carlezon, W. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012005 · Cited by 74
Clark, S. D., & Abi‐Dargham, A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.012 · Cited by 68
Ehrich, J. M., Phillips, P. E. M., & Chavkin, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.157 · Cited by 65
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Antiparkinsonian Action of a δ Opioid Agonist in Rodent and Primate Models of Parkinson's Disease
Hille, C. J., Fox, S. H., Maneuf, Y. P., Crossman, A. R., & Brotchie, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7763 · Cited by 65
Opioid Tolerance and the Emergence of New Opioid Receptor-Coupled Signaling
Gintzler, A. R., & Chakrabarti, S. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:1-2:021 · Cited by 64
Alderson, H. L., Parkinson, J. A., Robbins, T. W., & Everitt, B. J. (2000) · Psychopharmacology · doi:10.1007/s002130000634 · Cited by 67
Roles of opioid receptor subtypes in mediating alcohol‐seeking induced by discrete cues and context
Marinelli, P. W., Funk, D. R., Harding, S. E., Li, Z., Juzytsch, W., & Lê, A. D. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06851.x · Cited by 62
The role of δ‐opioid receptors in learning and memory underlying the development of addiction
Klenowski, P. M., Morgan, M., & Bartlett, S. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12618 · Cited by 60
μ‐Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
Hagelberg, N. M., Kajander, J., Någren, K., Hinkka‐Yli‐Salomäki, S., Hietala, J. A., & Scheinin, H. (2002) · Synapse · doi:10.1002/syn.10078 · Cited by 61
Svingos, A. L., Garzón, M., Colago, E. E. O., & Pickel, V. M. (2001) · Synapse · doi:10.1002/syn.1079 · Cited by 59
Effect of Enterostatin and Kappa-Opioids on Macronutrient Selection and Consumption
Ookuma, K., Barton, C., York, D. A., & Bray, G. A. (1997) · Peptides · doi:10.1016/s0196-9781(97)00029-6 · Cited by 59
Stimulatory effects of opioids
Harrison, C., Smart, D., & Lambert, D. G. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.20 · Cited by 59
Chefer, V. I., Kieffer, B. L., & Shippenberg, T. S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02912.x · Cited by 58
Ultradian rhythms in mammalian physiology and behavior
Prendergast, B. J., & Zucker, I. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.07.011 · Cited by 57
LeSage, M. G., Stafford, D. A., & Glowa, J. R. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00015-9 · Cited by 59
Chefer, V. I., Denoroy, L., Zapata, A. G., & Shippenberg, T. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06827.x · Cited by 58
Ventral tegmental area opioid mechanisms and modulation of ingestive behavior
Badiani, A., Leone, P., Noel, M. B., & Stewart, J. (1995) · Brain Research · doi:10.1016/0006-8993(94)01281-l · Cited by 57
Self-citationNaloxone attenuates incubated sucrose craving in rats
Grimm, J. W., Manaois, M., Osincup, D., Wells, B., & Buse, C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0868-y · Cited by 56
Ventral tegmental injections of a selective μ or δ opioid enhance feeding in food-deprived rats
Noel, M. B., & Wise, R. A. (1995) · Brain Research · doi:10.1016/0006-8993(94)01442-k · Cited by 56
Self-citationSmith, J. E., Co, C., Coller, M., Hemby, S. E., & Martin, T. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300786 · Cited by 56
Veer, A. V., Bechtholt, A. J., Onvani, S., Potter, D. N., Wang, Y., Liu‐Chen, L., Schütz, G., Chartoff, E. H., Rudolph, U., Cohen, B. M., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.58 · Cited by 59
Role of the Nucleus Accumbens and the Striatum in the Production of Turning Behaviour in Intact Rats
Koshikawa, N. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.4.331 · Cited by 55
Eiroá‐Orosa, F. J., Haasen, C., Verthein, U., Dilg, C., Schäfer, I., & Reimer, J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.013 · Cited by 54
Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice
Hutcheson, D. M., Matthes, H. W. D., Valjent, E., Sánchez‐Blázquez, P., Rodríguez‐Díaz, M., Garzón, J., Kieffer, B. L., & Maldonado, R. J. (2001) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2001.01363.x · Cited by 54
Doyon, W. M., Howard, E. C., Shippenberg, T. S., & Gonzales, R. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.005 · Cited by 53
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion
Margolis, E. B., & Karkhanis, A. N. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104504 · Cited by 56
Hipólito, L., Sánchez-Catalán, M. J., Zanolini, I., Polache, A., & Granero, L. M. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.012 · Cited by 52
Solecki, W., Turek, A., Kubik, J., & Przewłocki, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1672-7 · Cited by 52
Dai, X., Thavundayil, J., & Gianoulakis, C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000187599.17786.4a · Cited by 52
Noel, M. B., & Gratton, A. P. (1995) · Synapse · doi:10.1002/syn.890210204 · Cited by 51
Ikeda, H., Ardianto, C., Yonemochi, N., Yang, L., Ohashi, T., Ikegami, M., Nagase, H., & Kamei, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.002 · Cited by 50
David, V., Matifas, A., Gavello-Baudy, S., Decorte, L., Kieffer, B. L., & Cazala, P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301529 · Cited by 50
Sahr, A. E., Sindelar, D. K., Alexander-Chacko, J. T., Eastwood, B. J., Mitch, C. H., & Statnick, M. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00390.2007 · Cited by 50
The dynamic interaction between pain and opioid misuse
Wilson‐Poe, A. R., & Morón, J. A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13873 · Cited by 49
Šustková-Fišerová, M., Puskina, N., Havlickova, T., Lapka, M., Syslová, K., Pohorala, V., & Charalambous, C. (2019) · Addiction Biology · doi:10.1111/adb.12845 · Cited by 50
Hipólito, L., Sánchez-Catalán, M. J., Zornoza, T., Polache, A., & Granero, L. M. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1751-9 · Cited by 49
Mulholland, G. K., Wieland, D. M., Kilbourn, M. R., Frey, K. A., Sherman, P. S., Carey, J. E., & Kuhl, D. E. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199811)30:3 · Cited by 100
Tejeda, H. A., Natividad, L. A., Orfila, J. E., Torres, O. V., & O’Dell, L. E. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2752-7 · Cited by 47
Sánchez-Catalán, M. J., Hipólito, L., Zornoza, T., Polache, A., & Granero, L. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1495-6 · Cited by 48
Nestby, P., Schoffelmeer, A. N. M., Homberg, J. R., Wardeh, G., Vries, T. J. D., Mulder, A. H., & Vanderschuren, L. J. M. J. (1999) · Psychopharmacology · doi:10.1007/s002130050894 · Cited by 48
Ferguson, S. M., Thomas, M. J., & Robinson, T. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300465 · Cited by 48
Effect of chronic social stress on delta-opioid receptor function in the rat.
Pohorecky, L. A., Skiandos, A., Zhang, X., Rice, K. C., & Benjamin, D. (1999) · PubMed · Cited by 48
Akil, H., Meng, F., Devine, D. P., & Watson, S. J. (1997) · Seminars in Neuroscience · doi:10.1006/smns.1997.0108 · Cited by 48
Self-citationHipólito, L., Martí‐Prats, L., Sánchez-Catalán, M. J., Polache, A., & Granero, L. M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.04.014 · Cited by 47
Tolliver, B. K., Sganga, M. W., & Sharp, F. R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00214.x · Cited by 48
Opposite environmental regulation of heroin and amphetamine self-administration in the rat
Caprioli, D., Celentano, M., Paolone, G., Lucantonio, F., Bari, A., Nencini, P., & Badiani, A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1154-3 · Cited by 45
Could a common biochemical mechanism underlie addictions?
Betz, C., Mihalic, D., Pinto, M. E., & Raffa, R. B. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00260.x · Cited by 44
Vanderschuren, L. J. M. J., Schoffelmeer, A. N. M., Wardeh, G., & Vries, T. J. D. (2000) · Psychopharmacology · doi:10.1007/s002130000424 · Cited by 43
Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716
Singh, M. E., Verty, A. N. A., Price, I., McGregor, I. S., & Mallet, P. E. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.008 · Cited by 45
Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice
Elmer, G. I., Pieper, J. O., Levy, J., Rubinstein, M., Low, M. J., Grandy, D. K., & Wise, R. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0051-2 · Cited by 44
Self-citationSchad, C. A., Justice, J. B., & Holtzman, S. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.932 · Cited by 43
Burattini, C., Burbassi, S., Aicardi, G., & Cervo, L. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007705 · Cited by 43
Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats
Terry, P., & Katz, J. L. (1997) · Psychopharmacology · doi:10.1007/s002130050443 · Cited by 43
Kuzmin, A. V., Gerrits, M. A. F. M., & van Ree, J. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00637-2 · Cited by 43
Lepton, M., & Stewart, J. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02270-8 · Cited by 43
Paolone, G., Conversi, D., Caprioli, D., Bianco, P. D., Nencini, P., Cabib, S., & Badiani, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301388 · Cited by 42
Heidbreder, C. A., Shoaib, M. C., & Shippenberg, T. S. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00815-2 · Cited by 42
Effect of Chronic Ethanol on Enkephalin in the Hypothalamus and Extra‐Hypothalamic Areas
Chang, G., Barson, J. R., Karatayev, O., Chang, S. Y. A., Chen, Y., & LEIBOWITZ, S. F. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01148.x · Cited by 44
Ragnauth, A. K., Ruegg, H., & Bodnar, R. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00539-8 · Cited by 42
Modulation of cellular activity and synaptic transmission in the ventral tegmental area
Mathon, D. S., Kamal, A., Smidt, M. P., & Ramakers, G. M. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.097 · Cited by 41
Ramsey, N. F., Gerrits, M. A. F. M., & van Ree, J. M. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00009-1 · Cited by 41
Chiang, Y., Hung, T., & Ho, I. (2013) · Addiction Biology · doi:10.1111/adb.12055 · Cited by 40
Fu, K., Lin, H., Miyamoto, Y., Wu, C., Yang, J., Uno, K., & Nitta, A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4159-8 · Cited by 40
Opioid receptor modulation of feeding-evoked dopamine release in the rat nucleus accumbens
Taber, M. T., Zernig, G., & Fibiger, H. C. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01124-4 · Cited by 41
Celentano, M., Caprioli, D., Dipasquale, P., Cardillo, V., Nencini, P., Gaetani, S., & Badiani, A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1467-x · Cited by 40
Solecki, W., Ziolkowska, B., Krowka, T., Gieryk, A., Filip, M., & Przewlocki, R. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.002 · Cited by 39
Margolis, E. B., Fujita, W., Devi, L. A., & Fields, H. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.019 · Cited by 39
The effects of early life stress on motivated behaviors: A role for gonadal hormones
Eck, S. R., & Bangasser, D. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.014 · Cited by 40
Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine
Baumann, M. H., Pablo, J. P., Ali, S. F., Rothman, R. B., & Mash, D. C. (2001) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/s0099-9598(01)56009-5 · Cited by 39
Haloperidol Disrupts Opioid-Antinociceptive Tolerance and Physical Dependence
Yang, C., Chen, Y., Tang, L., & Wang, Z. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175539 · Cited by 38
Schenk, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00190-1 · Cited by 38
Rüedi‐Bettschen, D., Rowlett, J. K., Spealman, R. D., & Platt, D. M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1705-2 · Cited by 37
Methamphetamine-induced behavioral sensitization in mice: alterations in μ-opioid receptor
Chiu, C., Ma, T., & Ho, I. K. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9102-x · Cited by 37
Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections
Balcells‐Oliveró, M., & Vezina, P. (1997) · Psychopharmacology · doi:10.1007/s002130050288 · Cited by 37
Magendzo, K., & Bustos, G. A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300063 · Cited by 37
Ventral tegmental injections of morphine but not U-50,488H enhance feeding in food-deprived rats
Noel, M. B., & Wise, R. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91139-j · Cited by 37
Self-citationHummel, M., Ansonoff, M. A., Pintar, J. E., & Unterwald, E. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.025 · Cited by 36
Soderman, A. R., & Unterwald, E. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.035 · Cited by 36
Nielsen, C. K., Simms, J. A., Bito‐Onon, J. J., Li, R., Ananthan, S., & Bartlett, S. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00295.x · Cited by 36
The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research
Banks, M. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_268 · Cited by 36
WARD, S., & Roberts, D. C. S. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.05.003 · Cited by 34
Salt Appetite in Sodium-Depleted or Sodium-Replete Conditions: Possible Role of Opioid Receptors
Lucas, L., Grillo, C. A., & McEwen, B. S. (2007) · Neuroendocrinology · doi:10.1159/000102536 · Cited by 33
Ultrastructural localization of enkephalin and μ-opioid receptors in the rat ventral tegmental area
Garzón, M., & Pickel, V. M. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00249-x · Cited by 33
In vivo analysis of the role of dopamine in stimulant and opiate self-administration.
Gratton, A. P. (1996) · PubMed · Cited by 34
Acute δ-opioid receptor activation induces CREB phosphorylation in NG108-15 cells
Bilecki, W., Höllt, V., & Przewłocki, R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00018-2 · Cited by 32
Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine
Steinmiller, C. L. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01080-8 · Cited by 33
Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Escobar, A. P., Casanova, J. P., Andrés, M. E., & Fuentealba, J. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00057 · Cited by 32
Horner, K. A., Adams, D. H., Hanson, G. R., & Keefe, K. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.030 · Cited by 31
Dourmap, N., Cléro, É., & Costentin, J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01319-4 · Cited by 31
Mello, N. K., Mendelson, J. H., Sholar, M. B., Jaszyna-Gasior, M., Goletiani, N. V., & Siegel, A. J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300631 · Cited by 31
Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation
Pearl, S. M., Glick, S. D., & Johnson, D. W. (1995) · Psychopharmacology · doi:10.1007/bf02246495 · Cited by 31
Coutens, B., & Ingram, S. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109408 · Cited by 30
Peana, A. T., Muggironi, G., Fois, G. R., Zinellu, M., Vinci, S., & Acquas, E. (2011) · Alcohol · doi:10.1016/j.alcohol.2011.06.003 · Cited by 30
Liu, F., Jiang, H., Zhong, W., Wu, X., & Luo, J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.052 · Cited by 30
Naltrexone in the Treatment of Alcohol Dependence
Unterwald, E. M. (2008) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318182b20f · Cited by 30
George, T. P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00165-7 · Cited by 30
Effects of diabetes on spontaneous locomotor activity in mice
Kamei, J., Saitoh, A., Iwamoto, Y., Funada, M., Suzuki, T., Misawa, M., Nagase, H., & Kasuya, Y. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90292-5 · Cited by 29
Metadata
- Authors
- Devine, D. P., Leone, P., Pocock, D., & Wise, R. A.
- Affiliations
- Concordia University (CA)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1993-07
- Volume
- 266
- Issue
- 3
- Pages
- 1236-1246
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2108098398
- Cited by
- 382
- References
- 0
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 5 · 2017: 10 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 13 · 2012: 10
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institute on Drug Abuse (DA1720)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- ventral tegmental area, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, dopamine release, ventral striatum, dopamine metabolites, DAMGO, DPDPE, U50,488H, naltrindole, CTOP, mesolimbic dopamine system, opioid receptor selectivity, enkephalin, opioid agonists, opioid antagonists
- MeSH terms
- Amino Acid Sequence, Analgesics, Animals, Chromatography, High Pressure Liquid, Corpus Striatum, Dialysis, Dopamine, Enkephalins, Homovanillic Acid, Hydroxyindoleacetic Acid, Limbic System, Male, Microinjections, Molecular Sequence Data, Naltrexone, Narcotic Antagonists, Pyrrolidines, Rats, Inbred Strains, Receptors, Opioid, Tegmentum Mesencephali, 3,4-Dihydroxyphenylacetic Acid, 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Enkephalin, D-Penicillamine (2,5)-, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review